Valios Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 71.50 K
- Company Age 1 Year 1 Month
- Last Filing with ROC 31 Mar 2024
About Valios Life Sciences
Valios Life Sciences Private Limited (VLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 January 2024 (One year and one month 0 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 71.50 K , as per Ministry of Corporate Affairs (MCA) records.
Gurinder Khurana, Maunish Shah, and Kundanben Chavda serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U47721RJ2024PTC092101
-
Company No.
092101
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jan 2024
-
Date of AGM
11 Nov 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Who are the key members and board of directors at Valios Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurinder Khurana
|
Director | 12-Jan-2024 | Current |
|
Maunish Shah
|
Director | 12-Jan-2024 | Current |
|
Kundanben Chavda
|
Director | 12-Jan-2024 | Current |
Financial Performance of Valios Life Sciences.
Enhance accessibility to Valios Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Valios Life Sciences?
Unlock access to Valios Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Avis Biotec Private LimitedGurinder Khurana is a mutual person
-
Avis Lifecare Private LimitedGurinder Khurana and Maunish Shah are mutual person
-
Avis Pharmalabs Exim Private LimitedGurinder Khurana is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Valios Life Sciences?
Unlock and access historical data on people associated with Valios Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Valios Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valios Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.